Keywords: |
review; antineoplastic agent; neoplasms; animal; mice; interleukin 2; granulocyte macrophage colony stimulating factor; interleukin 4; animal experiment; recurrence; cyclophosphamide; drug resistance, neoplasm; europe; immunotherapy; medical education; gene therapy; transforming growth factor; medical oncology; rats; bone marrow transplantation; genetic markers; genes, lethal; gene transfer techniques; biological response modifier; biological response modifiers; mafosfamide; cancer; human; priority journal; support, non-u.s. gov't
|